the risk of jaw bone damage while taking Fosamax or other bisphosphonates

August 2006

Lots of worried patients are asking about the risk of jaw bone damage while taking Fosamax or other bisphosphonates.

Questions about this osteonecrosis of the jaw have really picked up since we alerted you to this rare problem last year.

Patients are now hearing about it from the lay press...and from the many ads from lawyers looking for cases.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote